This website uses cookies to enhance the user experience.
V

VITUX PHARMA AS985 318 271

Research
Limited company
Brynsveien 11-13 0667 OSLO, Norge
Services
/ Research
/ 72.190 Other research and experimental development on natural sciences and engineering

VITUX PHARMA AS

Keywords

researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research

Organization

CEO
KW

Klaus Wilhelm Neumann1963

Chairman of the board
KW

Klaus Wilhelm Neumann1963

Years since formation
22 years
since Jan 31, 2003
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
24,410
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Annual total result 2024
18,945
NOK
Total equity 2024
1,588,825
NOK
Last update: Jul 3, 2025

Management

Management / administration

NameRoleShares
KW

Klaus Wilhelm Neumann

1963

Managing Director/CEO-

Board

NameRoleShares
KW

Klaus Wilhelm Neumann

1963

Chairman-
CE

Camilla Engelberg Bakken

1975

Board Member-

Others

NameRoleShares
K
KPMG AS
Auditor-
B
BDO AS
Accountant-

Top 10 individual shareholders

NameRoleShares
BM

Bjørn Margido Wiggen

1959

-
15.59 %
indirectly
PO

Per Olav Monseth

1979

-
1.06 %
indirectly
Last update: Jul 18, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
V
VITUX GROUP AS
Ordinary shares
24,410
100 %
Last update: Jun 2, 2025

Group structure

  • SALVESEN & THAMS AS
    Total operating income 2023: NOK 200,000
    Operating profit 2023: NOK -5,327,849
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
0
0
0
0
Annual Total Result
18,945
26,324
-5,108
-26,916
Total assets
1,638,384
1,569,880
1,562,306
1,548,664
Total liabilities
49,560
0
18,750
0
Total equity
1,588,825
1,569,880
1,543,556
1,548,664

P&L

Year2024202320222021
Total operating income
0
0
0
0
Total operating costs
72,060
57,466
63,961
48,058
Operating result
-72,060
-57,466
-63,961
-48,058
Financial income/costs
91,005
83,790
58,853
21,142
Profit before tax
18,945
26,324
-5,108
-26,916
Total tax & extraordinary income/cost
0
0
0
0
Annual Total Result
18,945
26,324
-5,108
-26,916

Balance overview

Year2024202320222021
Total fixed assets
1,563,897
1,462,314
1,470,304
865,924
Total current assets
74,487
107,566
92,002
682,740
Total assets
1,638,384
1,569,880
1,562,306
1,548,664
Short term debt
49,560
0
18,750
0
Long term debt
0
0
0
0
Total liabilities
49,560
0
18,750
0
Contributed capital
31,168,202
31,168,202
31,168,202
31,168,202
Retained earnings
-29,579,377
-29,598,322
-29,624,646
-29,619,538
Total equity
1,588,825
1,569,880
1,543,556
1,548,664
Total equity and liabilities
1,638,385
1,569,880
1,562,306
1,548,664

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering